Browsing Tag
cardiac stress agents
1 post
Can Glenmark Pharmaceuticals’ tentative FDA nod for Regadenoson Injection boost its US generics momentum?
Glenmark Pharmaceuticals secures FDA tentative approval for Regadenoson Injection, targeting a USD 660M U.S. cardiac stress agent market.